Post-COVID Conditions: Clinical Trials

2 trials for Post-COVID Conditions, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Not yet recruiting 1, Recruiting 1

Follow Post-COVID Conditions: new trials by email Literature Review of Post-COVID Conditions trials Research Report on Post-COVID Conditions

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Transcranial Direct Current Stimulation for Long COVID Brain Fog and Fatigue
Transcranial Direct Current Stimulation - Long COVID, Post-COVID Conditions
Not applicableNot yet recruitingUniversity of Las Palmas de Gran Canaria202026-09-152026-07-22
Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
12-weeks of Weight Loss, 12-weeks of Weight Stability - Post-COVID Conditions, Obesity
Not applicableRecruitingVA Office of Research and Development1502024-06-032026-06-01

Narrower conditions

Post-Acute COVID-19 Syndrome (2)  ·  COVID-19 (1)  ·  Cognitive Dysfunction (1)  ·  Fatigue (1)  ·  Mental Fatigue (1)  ·  Motor Activity (1)  ·  Obesity (1)  ·  Weight Loss (1)

Broader conditions

Behavior (2)  ·  Chronic Disease (2)  ·  Coronaviridae Infections (2)  ·  Coronavirus Infections (2)  ·  Disease Attributes (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Nidovirales Infections (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  Post-Infectious Disorders (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)

Interventions

Transcranial Direct Current Stimulation (1)

Sponsors

University of Las Palmas de Gran Canaria (1)  ·  VA Office of Research and Development (1)

Countries

United States (1)

Top investigators

Alice S. Ryan, PhD (1)  ·  Juan Francisco Vigueras, MD (1)

NIH funding

I01RX004572 (1)